Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid

Lipids

Volumn 44, Issue 10, 2009, Pages 953-961

  Carballeira, Néstor M ^a   Cartagena, Michelle M ^a   Prada, Christopher Fernández ^b   Rubio, Celia Fernández ^b   Balaña Fouce, Rafael ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF LEÓN   (Spain)

Author keywords

Acetylenic fatty acids; Antiprotozoal activity; Leishmania donovani; Synthesis; Topoisomerase IB

Indexed keywords

6 HEPTADECYNOIC ACID; 6 ICOSYNOIC ACID; ANTILEISHMANIAL AGENT; DNA TOPOISOMERASE; FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; ENZYME INHIBITION; FATTY ACID DESATURATION; LEISHMANIA DONOVANI; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ALKYNES; ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; FATTY ACIDS, UNSATURATED; LEISHMANIA DONOVANI; MICE;

LEISHMANIA DONOVANI;

EID: 70350218658     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-009-3345-z     Document Type: Article

References (15)

1. X-C Li MR Jacob SI Khan MK Ashfaq KS Babu AK Agarwal HN ElSohly SP Manly AM Clark 2008 Potent in vitro antifungal activities of naturally occurring acetylenic acids Antimicrob Agents Chemother 52 2442 2448
2. MB Pearl R Kleiman FR Earle 1973 Acetylenic acids of Alvaradoa amorphoides seed oil Lipids 8 627 630
3. NM Carballeira E Anastacio J Salvá MJ Ortega 1992 Identification of the new 10, 15-eicosadienoic acid and related acids in the opisthobranch Haminaea templadoi J Nat Prod 55 1783 1786
4. NM Carballeira M Pagán F Shalabi JT Nechev K Lahtchev A Ivanova K Stefanov 2000 Two novel iso-branched octadecenoic acids from a Micrococcus species J Nat Prod 63 1573 1575
5. G Chaudhuri K Ghoshal AB Banerjee 1986 Toxic effects of fatty acids on Leishmania donovani promastigotes Indian J Med Res 84 361 365
6. P Desjeux 2004 Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis 27 305 318
7. J Berman 2006 Visceral leishmaniasis in the New World & Africa Indian J Med Res 123 289 294 (Pubitemid 43905570)
8. I Cruz J Nieto J Moreno C Cañavate P Desjeux J Alvar 2006 Leishmania/HIV co-infections in the second decade Indian J Med Res 123 357 388
9. R Balaña-Fouce JC Cubría RM Reguera D Ordóñez 1998 The pharmacology of leishmaniasis Gen Pharmacol 30 435 443 (Pubitemid 28102818)
10. P Marty E Rosenthal 2002 Treatment of visceral leishmaniasis: a review of current treatment practices Expert Opin Pharmacother 3 1101 1108
11. J Berman 2005 Miltefosine to treat leishmaniasis Expert Opin Pharmacol 6 1381 1388
12. S Sundar J Chakravarty 2008 Paromomycin in the treatment of leishmaniasis Expert Opin Investig Drugs 17 787 794
13. S Bhattacharya PK Sinha S Sundar CP Thakur TK Jha K Pandey VR Das N Kumar C Lal N Verma VP Singh A Ranjan RB Verma G Anders H Sindermann NK Ganguly 2007 Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis J Infect Dis 196 591 598 (Pubitemid 47206107)
14. H Villa AR Otero Marcos RM Reguera R Balaña-Fouce C García-Estrada Y Pérez-Pertejo BL Tekwani PJ Tyler KD Stuart MA Bjornsti DA Ordóñez 2003 A novel active DNA topoisomerase I in Leishmania donovani J Biol Chem 278 3521 3526
15. R Diaz-González Y Pérez-Pertejo Y Pommier R Balaña-Fouce RM Reguera 2008 Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: role of Asp-353 and Asn-221 in camptothecin resistance Biochem Pharmacol 76 608 619